NYMC Faculty Publications
DOI
10.1182/bloodadvances.2017013052
Journal Title
Blood Advances
First Page
1022
Last Page
1031
Document Type
Article
Publication Date
5-1-2018
Department
Pediatrics
Abstract
Optimal donor selection is critical for successful allogeneic hematopoietic cell transplantation (HCT). Donor sex and parity are well-established risk factors for graft-versus-host disease (GVHD), with male donors typically associated with lower rates of GVHD. Well-matched unrelated donors (URDs) have also been associated with increased risks of GVHD as compared with matched sibling donors. These observations raise the question of whether male URDs would lead to more (or less) favorable transplant outcomes as compared with parous female sibling donors. We used the Center for International Blood and Marrow Transplant Research registry to complete a retrospective cohort study in adults with acute myeloid leukemia, acute lymphoblastic leukemia, or myelodysplastic syndrome, who underwent T-cell replete HCT from these 2 donor types (parous female sibling or male URD) between 2000 and 2012. Primary outcomes included grade 2 to 4 acute GVHD (aGVHD), chronic GVHD (cGVHD), and overall survival. Secondary outcomes included disease-free survival, transplant-related mortality, and relapse. In 2813 recipients, patients receiving male URD transplants (n = 1921) had 1.6 times higher risk of grade 2 to 4 aGVHD (P < .0001). For cGVHD, recipient sex was a significant factor, so donor/recipient pairs were evaluated. Female recipients of male URD grafts had a higher risk of cGVHD than those receiving parous female sibling grafts (relative risk [RR] = 1.43, P < .0001), whereas male recipients had similar rates of cGVHD regardless of donor type (RR = 1.09, P = .23). Donor type did not significantly affect any other end point. We conclude that when available, parous female siblings are preferred over male URDs.
Recommended Citation
Kumar, A. J., Kim, S., Hemmer, M., Arora, M., Spellman, S., Cairo, M., & Loren, A. (2018). Graft-Versus-Host Disease in Recipients of Male Unrelated Donor Compared with Parous Female Sibling Donor Transplants. Blood Advances, 2 (9), 1022-1031. https://doi.org/10.1182/bloodadvances.2017013052
Publisher's Statement
Originally published in Blood Advances, 2(9), 1022-1031. The original material can be found here.
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Comments
Please see the work itself for the complete list of authors